HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aprotinin modifies left ventricular contractility and cytokine release after ischemia-reperfusion in a dose-dependent manner in a murine model.

AbstractBACKGROUND:
Periods of ischemia-reperfusion (I/R) during cardiac surgery are associated with transient left ventricular (LV) dysfunction and an inflammatory response. In this study, we examined the potential dose-dependent effects of aprotinin (APRO) on LV contractility and cytokine release in the setting of I/R.
METHODS:
An index of LV contractility, LV maximal elastance (E(max)), was measured at baseline, 30 min of ischemia, and 60 min of reperfusion by microtransducer volumetry. Mice were randomized as follows: (a) APRO 20,000 kallikrein-inhibiting units (KIU)/kg (n = 11); (b) APRO 4 x 10(4) KIU/kg (n = 10); (c) APRO 8 x 10(4) KIU/kg (n = 10); and (d) vehicle (saline; n = 10). APRO doses were calculated to reflect half, full, and twice the clinical Hammersmith dosing schedule. After I/R, plasma was collected for cytokine measurements.
RESULTS:
After I/R, E(max) decreased from the baseline value by more than 40% in the vehicle group as well as in the APRO 4 x 10(4) KIU/kg and APRO 8 x 10(4) KIU/kg groups (P < 0.05). However, E(max) returned to near baseline values in the APRO 2 x 10(4) KIU/kg group. Tumor necrosis factor (TNF) increased 10-fold after I/R, but it was reduced with higher APRO doses.
CONCLUSIONS:
This study demonstrated that a low dose of APRO provided protective effects on LV contractility, whereas higher doses suppressed TNF release. These unique findings suggest that there are distinct and independent mechanisms of action of APRO in the context of I/R.
AuthorsMatthew D McEvoy, Michel J Sabbagh, Anna Greta Taylor, Juozas A Zavadzkas, Christine N Koval, Robert E Stroud, Rachael L Ford, Julie E McLean, Scott T Reeves, Rupak Mukherjee, Francis G Spinale
JournalAnesthesia and analgesia (Anesth Analg) Vol. 108 Issue 2 Pg. 399-406 (Feb 2009) ISSN: 1526-7598 [Electronic] United States
PMID19151263 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Cytokines
  • Hemostatics
  • Tumor Necrosis Factor-alpha
  • Aprotinin
Topics
  • Animals
  • Aprotinin (blood, pharmacology)
  • Arrhythmias, Cardiac (etiology, physiopathology)
  • Cytokines (metabolism)
  • Dose-Response Relationship, Drug
  • Elasticity
  • Hemodynamics (physiology)
  • Hemostatics (blood, pharmacology)
  • Kinetics
  • Mice
  • Myocardial Contraction (drug effects)
  • Myocardial Reperfusion Injury (metabolism, physiopathology)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Ventricular Function, Left (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: